| LIFEx: A Freeware for Radiomic Feature Calculation in Multimodality Imaging to Accelerate Advances in the Characterization of Tumor Heterogeneity |
93 |
| Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN/PI3K gamma to Promote Pancreatic Cancer Metastasis |
87 |
| The Critical Role of RNA m(6)A Methylation in Cancer |
87 |
| The Tumor Microenvironment Innately Modulates Cancer Progression |
79 |
| Diverse Functions of Macrophages in Different Tumor Microenvironments |
73 |
| CircNT5E Acts as a Sponge of miR-422a to Promote Glioblastoma Tumorigenesis |
67 |
| The Circular RNA circPRKCI Promotes Tumor Growth in Lung Adenocarcinoma |
63 |
| M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer |
60 |
| PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness |
58 |
| Defining the Hallmarks of Metastasis |
56 |
| Transfer of miRNA in Macrophage-Derived Exosomes Induces Drug Resistance in Pancreatic Adenocarcinoma |
53 |
| A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment |
51 |
| Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3 |
50 |
| Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment |
49 |
| Twist1 Regulates Vimentin through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma |
48 |
| Pleiotropic Roles for ZEB1 in Cancer |
48 |
| AKT as a Therapeutic Target for Cancer |
48 |
| microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer |
46 |
| Targeting Rac and Cdc42 GTPases in Cancer |
45 |
| Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner |
44 |
| Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis |
42 |
| CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8(+) T Cells |
42 |
| Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize |
41 |
| Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer |
41 |
| NRF2 Activation in Cancer: From DNA to Protein |
40 |
| EGR1-Mediated Transcription of lncRNA-HNF1A-AS1 Promotes Cell-Cycle Progression in Gastric Cancer |
38 |
| The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1 |
38 |
| Posttranslational Modifications of PD-L1 and Their Applications in Cancer Therapy |
38 |
| miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes |
37 |
| Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis |
36 |
| Long Noncoding RNA MIR17HG Promotes Colorectal Cancer Progression via miR-17-5p |
36 |
| MDM2-Recruiting PROTAC Offers Superior, Synergistic Antiproliferative Activity via Simultaneous Degradation of BRD4 and Stabilization of p53 |
35 |
| Metabolic Imaging of the Human Brain with Hyperpolarized C-13 Pyruvate Demonstrates C-13 Lactate Production in Brain Tumor Patients |
35 |
| Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence |
35 |
| Long Noncoding RNA MALAT1 Regulates Cancer Glucose Metabolism by Enhancing mTOR-Mediated Translation of TCF7L2 |
35 |
| NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma |
33 |
| Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma |
33 |
| Genetic Ablation of the Cystine Transporter xCT in PDAC Cells Inhibits mTORC Growth, Survival, and Tumor Formation via Nutrient and Oxidative Stresses |
32 |
| Inhibition of the Wnt/beta-Catenin Pathway Overcomes Resistance to Enzalutamide in Castration-Resistant Prostate Cancer |
32 |
| A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53 |
31 |
| LncRNA SNHG10 Facilitates Hepatocarcinogenesis and Metastasis by Modulating Its Homolog SCARNA13 via a Positive Feedback Loop |
31 |
| An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells |
31 |
| MYC Targeted Long Noncoding RNA DANCR Promotes Cancer in Part by Reducing p21 Levels |
31 |
| Silencing of Long Noncoding RNA MIR22HG Triggers Cell Survival/Death Signaling via Oncogenes YBX MET, and p21 in Lung Cancer |
31 |
| Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma |
30 |
| Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine |
30 |
| Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer |
29 |
| Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms |
29 |
| Tumor-Educated Platelets as a Noninvasive Biomarker Source for Cancer Detection and Progression Monitoring |
29 |
| Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade |
29 |
